Zuckerman KS - Search Results

1

Identification of a novel inhibitor of JAK2 tyrosine kinase by structure-based virtual screening.

Kiss R, Polgár T, Kirabo A, Sayyah J, Figueroa NC, List AF, Sokol L, Zuckerman KS, Gali M, Bisht KS, Sayeski PP, Keseru GM. Kiss R, et al. Among authors: zuckerman ks. Bioorg Med Chem Lett. 2009 Jul 1;19(13):3598-601. doi: 10.1016/j.bmcl.2009.04.138. Epub 2009 May 5. Bioorg Med Chem Lett. 2009. PMID: 19447617 Free PMC article.

2

Chemotherapy-related anemia.

Visweshwar N, Jaglal M, Sokol L, Zuckerman K. Visweshwar N, et al. Ann Hematol. 2018 Feb;97(2):375-376. doi: 10.1007/s00277-017-3155-y. Epub 2017 Nov 4. Ann Hematol. 2018. PMID: 29103107 No abstract available.

3

The Treatment Landscape of Myelofibrosis Before and After Ruxolitinib Approval.

Kuykendall AT, Talati C, Al Ali N, Sweet K, Padron E, Sallman DA, Lancet JE, List AF, Zuckerman KS, Komrokji RS. Kuykendall AT, et al. Among authors: zuckerman ks. Clin Lymphoma Myeloma Leuk. 2017 Dec;17(12):e45-e53. doi: 10.1016/j.clml.2017.08.002. Epub 2017 Aug 5. Clin Lymphoma Myeloma Leuk. 2017. PMID: 28869184

4

Between a rux and a hard place: evaluating salvage treatment and outcomes in myelofibrosis after ruxolitinib discontinuation.

Kuykendall AT, Shah S, Talati C, Al Ali N, Sweet K, Padron E, Sallman DA, Lancet JE, List AF, Zuckerman KS, Komrokji RS. Kuykendall AT, et al. Among authors: zuckerman ks. Ann Hematol. 2018 Mar;97(3):435-441. doi: 10.1007/s00277-017-3194-4. Epub 2017 Nov 30. Ann Hematol. 2018. PMID: 29189896

5

Monocyte subset analysis accurately distinguishes CMML from MDS and is associated with a favorable MDS prognosis.

Talati C, Zhang L, Shaheen G, Kuykendall A, Ball M, Zhang Q, Lancet JE, Zuckerman KS, List AF, Komrokji R, Moscinski L, Padron E. Talati C, et al. Among authors: zuckerman ks. Blood. 2017 Mar 30;129(13):1881-1883. doi: 10.1182/blood-2016-12-753210. Epub 2017 Feb 3. Blood. 2017. PMID: 28159734 Free article. No abstract available.

6

Clonality in juvenile chronic myelogenous leukemia.

Busque L, Gilliland DG, Prchal JT, Sieff CA, Weinstein HJ, Sokol JM, Belickova M, Wayne AS, Zuckerman KS, Sokol L, et al. Busque L, et al. Among authors: zuckerman ks. Blood. 1995 Jan 1;85(1):21-30. Blood. 1995. PMID: 7803795 Free article.

7

Clinical prognostic factors and outcomes of essential thrombocythemia when transformed to myelodysplastic syndromes and acute myeloid leukemia.

Suleiman Y, Dalia S, Liu JJ, Bowers JW, Padron E, Lancet JE, Fulp W, Moscinski LC, Komrokji RS, Zuckerman KS, Zhang L. Suleiman Y, et al. Among authors: zuckerman ks. Leuk Res. 2016 Mar;42:52-8. doi: 10.1016/j.leukres.2016.01.015. Epub 2016 Feb 2. Leuk Res. 2016. PMID: 26894965

8

Value of positron emission tomography scan in staging cancers, and an unusual presentation of acute myeloid leukemia. Case 3. Acute myeloid leukemia presenting with lytic bone lesions.

Johnson JL, Moscinski L, Zuckerman K. Johnson JL, et al. J Clin Oncol. 2004 Jul 15;22(14):2968-70. doi: 10.1200/JCO.2004.09.032. J Clin Oncol. 2004. PMID: 15254066 No abstract available.

9

Transforming growth factor beta inhibits growth of more differentiated myeloid leukemia cells and retinoblastoma protein phosphorylation at serine 795.

Hu X, Moscinski LC, Zuckerman KS. Hu X, et al. Among authors: zuckerman ks. Exp Hematol. 1999 Apr;27(4):605-14. doi: 10.1016/s0301-472x(99)00004-1. Exp Hematol. 1999. PMID: 10210318 Free article.

10

TGFbeta regulates the expression and activities of G2 checkpoint kinases in human myeloid leukemia cells.

Hu X, Cui D, Moscinski LC, Zhang X, Maccachero V, Zuckerman KS. Hu X, et al. Among authors: zuckerman ks. Cytokine. 2007 Feb;37(2):155-62. doi: 10.1016/j.cyto.2007.03.009. Epub 2007 Apr 24. Cytokine. 2007. PMID: 17459720

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

74 results

Search Page